Literature DB >> 2563516

Misuse of verapamil in pre-excited atrial fibrillation.

C Garratt1, A Antoniou, D Ward, A J Camm.   

Abstract

Of 18 patients who attended accident and emergency departments with pre-excited atrial fibrillation, 10 were inappropriately treated with intravenous verapamil. The reason for the inappropriate treatment was misdiagnosis of the arrhythmia, although diagnostic electrocardiograms were available for all patients: in only 3 of the 18 patients was the correct diagnosis made before intervention. Misdiagnosis occurred because of failure to consider pre-excitation as a possible diagnosis, rather than bias towards a single alternative arrhythmia. The use of intravenous verapamil was associated with deterioration in the clinical condition of 6 patients and continued arrhythmia in all 10.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563516     DOI: 10.1016/s0140-6736(89)91734-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

Review 1.  Atrial fibrillation. The therapeutic options.

Authors:  R V Lewis
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

2.  Diagnosis and management of ventricular tachycardia.

Authors:  O M Jolobe
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

Review 3.  Atrial fibrillation pearls and perils of management.

Authors:  P J Kudenchuk
Journal:  West J Med       Date:  1996-05

4.  Atrial Fibrillation in a Patient With an Accessory Pathway.

Authors:  Andrew Silverman; Sonia Taneja; Liliya Benchetrit; Peter Makusha; Robert L McNamara; Alexander B Pine
Journal:  J Investig Med High Impact Case Rep       Date:  2018-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.